Indapamide 2.5mg Sustained-Release Tablets from Japan
Indapamide is a thiazide-like diuretic with vasodilatory properties for essential hypertension treatment. HTS 3004.90.92.63 covers this measured-dose, sustained-release form affecting caloric and electrolytic balance, packaged for retail sale. Designed for once-daily patient administration.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit extended-release dissolution testing results for FDA import review
• Label with lipid metabolism effect disclosures for this diuretic class
• Confirm controlled-release mechanism qualifies as measured-dose product